Loading…
Artelo Biosciences Inc Is A United States-Based Development-Stage Biopharmaceutical Company. It Is Engaged In The Development Of Therapeutics That Target Lipid Signaling Pathways, Including The Endocannabinoid System, A Family Of Receptors & Neurotransmitters That Form A Biochemical Communication Network In The Body. It Is Focused On Discovering, Licensing, Developing, & Commercializing Treatments That Control Endocannabinoid Systems. The Company Pursues Technologies & Programs That Offer Proprietary Approaches To Cannabinoid-Based Therapies, & Those Derived From The Cannabis Plant & Synthetic Cannabinoids, As Well As New Chemical Entities & Compounds. The Firm'S Flagship Program Is Designed To Be A Patent-Protected Cannabinoid Drug Combination Treatment For A Rare & Orphan Disease.